AMLI 2024 Assay Offering: BUHLMANN is proud to partner with this event. We offer a comprehensive Immunology assay product line comprised of robust assays for simple, esoteric testing for important markers and it is supported by numerous publications. Visit www.buhlmannlabs.com or email info@buhlmannlabs.com for more information. AMLI 2024 37th AMLI Annual Meeting Aug 16-19,
Continue Reading
Tag: BÜHLMANN fCAL® ELISA
AMLI 2023 Assay Offering: BUHLMANN is proud to partner with this event. We offer a comprehensive Immunology assay product line comprised of robust assays for simple, esoteric testing for important markers and it is supported by numerous publications. Visit www.buhlmannlabs.com or email info@buhlmannlabs.com for more information. AMLI 2023 36th AMLI Annual Meeting Aug 11-14,
Continue Reading
We offer a comprehensive autoimmunity product line comprised of robust assays for simple, esoteric testing for important markers and it is supported by numerous publications. Anti-MAG Autoantibodies ELISA US: Research Use Only. Not for use in diagnostic procedures. Canada: Health Canada License: 89118 This assay is intended for the quantitative determination of human IgM-auto-antibodies directed
Continue Reading
BÜHLMANN fCAL® ELISA is FDA 510(k) cleared. For in vitro Diagnostic Use. Health Canada License: 80726 Abstract Inflammatory Bowel Disease (IBD) is a chronic inflammatory disease of the gut, which presents with periods of inflammatory activity (flares) and quiescent phases (remission) as can be seen in many chronic diseases. IBD includes several different diseases; the two most important
Continue Reading
BÜHLMANN fCAL® ELISA is FDA 510(k) cleared. For in vitro Diagnostic Use. Health Canada License: 80726 In this Video You will Learn: Background information on calprotectin and it’s use in primary care Technical details of calprotectin testing in the laboratory Perspectives and general tips on the use of the BÜHLMANN fCAL® ELISA Contact our team and learn more about
Continue Reading
In this "Summer Edition" we are pleased to announce the FDA 510 (k) clearance of the BÜHLMANN fCAL® ELISA. We make mention of upcoming meetings where you can find us such as American Association of Clinical Chemistry (AACC) and the Association of Medical Laboratory Immunologists (AMLI) annual meetings. Additionally, we share the exciting happenings pertaining to
Continue Reading
BÜHLMANN fCAL® ELISA, an in vitro diagnostic assay intended for the quantitation of calprotectin in human stool, has received 510(k) clearance from the Food and Drug Administration (FDA) and is now commercially available in the US. Amherst NH, June 12, 2018: BÜHLMANN Laboratories AG, is proud to announce it has received United States Food and
Continue Reading
